Stem cell research in Ukraine is funded by the European Cooperation in Science and Technology

Cell technologies are one of the most promising directions in modern medicine. Most of the Nobel Prizes of the last decade have been awarded for the achievements in molecular and cell biology.

In developed countries, more and more grants from government and nonprofit organizations are allocated annually to stem cell research.

An indicator of the competitiveness of Ukrainian science in the field of cell technologies can be considered the fact that Ukrainian cryobank, the co-founder and a member of the Association of Cryobanks – Institute for Cell Therapy recently has received a grant from the European Cooperation in Science and Technology (COST).

The European Cooperation in Science and Technology (headquartered in the city of Brussels (Belgium) integrates competent academical, clinical and industrial centers for basic research of perinatal tissues (umbilical cord, placenta) and promotes translational research, i.e. being on stage of introduction into health care system. For almost 50 years the European Cooperation in Science and Technology has been funding the most promising research projects from the budget in the framework of the European Union programs, including Horizont 2020.

The Institute of Cell Therapy is involved in the implementation of the international project COST action CA17116 on placental stem cells.

Established in 2013, the Association of Cryobanks of Umbilical Cord Blood and Other Human Tissues and Cells in Ukraine is a unique professional association of licensed biobanks, scientific and medical centers, working in the field of cryopreservation and stem cell research. The Association of Cryobanks promotes the development of biobanking in Ukraine within the legal framework and provision of quality services on the cryoconservation of cord blood components, the placenta, umbilical cord and other tissues and cells.

No Comments Yet.

Leave a comment

You must be logged in to post a comment.